Unnatural Endotype B PPAPs as Novel Compounds with Activity against <i>Mycobacterium tuberculosis</i>-Reference-Cited by-同舟云学术

Unnatural Endotype B PPAPs as Novel Compounds with Activity against Mycobacterium tuberculosis

Published:2023-10-12 Issue:22 Volume:66 Page:15073-15083
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Peslalz Philipp¹,Grieshober Mark²,Kraus Frank³,Bleisch Anton¹,Izzo Flavia³,Lichtenstein Dajana⁴^ORCID,Hammer Helen⁵,Vorbach Andreas⁶,Momoi Kyoko⁷,Zanger Ulrich M.⁷,Brötz-Oesterhelt Heike⁶⁸^ORCID,Braeuning Albert⁴,Plietker Bernd¹³^ORCID,Stenger Steffen²

Affiliation:

1. Chair of Organic Chemistry, Faculty of Chemistry and Food Chemistry, Technical University Dresden, Bergstr. 66, Dresden01069 ,Germany

2. Institute for Medical Microbiology and Hygiene, University Hospital Ulm, Albert-Einstein-Allee 11, Ulm D-89081, Germany

3. Institut für Organische Chemie, Universität Stuttgart,Pfaffenwaldring 55, Stuttgart 70569, Germany

4. Department of Food Safety, German Federal Institute for Risk Assessment, Max-Dohrn-Str. 8-10, Berlin 10589, Germany

5. SIGNATOPE GmbH, Markwiesenstr. 55, Reutlingen 72770, Germany

6. Interfaculty Institute of Microbiology and Infection Medicine, Tübingen 72076, Germany

7. Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology Auerbachstr. 112, University of Tübingen, 70376 Stuttgart, Tübingen 72076, Germany

8. German Center for Infection Research, Partner Site Tübingen, Tübingen 72076, Germany

Funder

Robert Bosch Stiftung

Deutsche Forschungsgemeinschaft

Bundesinstitut f?r Risikobewertung

Ministerium f?r Wissenschaft und Kultur Baden-W?rttemberg

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c01172

Reference54 articles.

1. Drug-resistant tuberculosis: time for visionary political leadership

2. Global Tuberculosis Report 2022. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022 (accesseed 2023–03–22).

3. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

4. Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis

5. Advances in the development of new tuberculosis drugs and treatment regimens

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and synthesis of Thieno[3, 2-b]pyridinone derivatives exhibiting potent activities against Mycobacterium tuberculosis in vivo by targeting Enoyl-ACP reductase;European Journal of Medicinal Chemistry;2024-12

2. Chemical Predictive Modelling and Natural Product‐based Divergent Synthesis – Design of Type B PPAPs with Nanomolar Activities against MRSA;Chemistry – A European Journal;2024-07-29

3. Antimicrobial Evaluation of Two Polycyclic Polyprenylated Acylphloroglucinol Compounds: PPAP23 and PPAP53;International Journal of Molecular Sciences;2024-07-23